Table 5 The sensitivity analysis at 25% sharing rate for marginal annual cost saving, cost - effectiveness and cost – benefit of SIF in Montreal
Variables | Annual cost of operation | Sharing rate | # of HIV averted | # of HCV averted | HIV cost saved | HCV cost saved | Cost-effectiveness ratio HCV | Cost-effectiveness ratio HIV | Cost-benefit ratio HCV | Cost-benefit ratio HIV |
|---|---|---|---|---|---|---|---|---|---|---|
Post SIF | $2,182,800 | 25% | 10 | 64 | -$77,250 | $66,352 | $34,106 | $218,280 | 1.03 | 1 |
Two SIF | $2,182,800 | 20% | 9 | 55 | -$287,805 | -$249,935 | $39,687 | $242,533 | 0.89 | 0.87 |
Three SIF | $2,182,800 | 15% | 4 | 24 | -$1,340,580 | -$1,339,368 | $90,950 | $545,700 | 0.39 | 0.39 |
Four SIF | $2,182,800 | 13% | 4 | 24 | -$1,340,580 | -$1,339,368 | $90,950 | $545,700 | 0.39 | 0.39 |
Five SIF | $2,182,800 | 11% | 4 | 24 | -$1,340,580 | -$1,339,368 | $90,950 | $545,700 | 0.39 | 0.39 |
Six SIF | $2,182,800 | 9.00% | 4 | 24 | -$1,340,580 | -$1,339,368 | $90,950 | $545,700 | 0.39 | 0.39 |
Seven SIF | $2,182,800 | 7% | 4 | 24 | -$1,340,580 | -$1,339,368 | $90,950 | $545,700 | 0.39 | 0.39 |
Average | $2,182,800 | 14% | 6 | 34 | -$919,470 | -$987,938 | $64,200 | $363,800 | 0.55 | 0.58 |